Power your decentralized trial with an agile randomization and trial supply management solution that supports supply flexibility and optimization as well as adaptable direct to patient options.
Artificial intelligence (AI) and machine learning (ML) are revolutionizing various domains worldwide. Industries are leveraging AI for clinical systems, tracking, direct-to-patient services, advanced therapeutics, distribution, and cost-saving supply forecasting. As we navigate this transformative landscape, key questions emerge: How can we enhance technology to ensure safety and accountability while minimizing costs and risks?
Key learning objectives:
- Building a strong and productive partnership: history and lessons learned
- Case study: isolating objectives and delivering results through technology
- Emerging technologies, risks and regulatory considerations: identifying the use cases for AI/ML
Vice President & General Manager, IRT, IQVIA Technologies
Senior Director of Product Management, IQVIA IRT
Related solutions
Learn how unparalleled data, domain expertise, and technologies enable AI-powered solutions that are purpose-built for healthcare.
